Advanced Search

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 2) (No. PB 4 of 2013)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
PB 4 of 2013
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013
(No. 2)1
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953.
Dated 21 January 2013
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2013 (No. 2).
            (2)        This Instrument may also be cited as PB 4 of 2013.
2          Commencement
This Instrument commences on 22 January 2013.
3          Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)
            Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).
Schedule 1     Amendments
 
[1]           Schedule 1, after entry for Morphine in the form Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL
insert in the columns in the order indicated:
 
Injection containing morphine sulphate 10 mg in 1 mL (with preservative)
Injection
Morphine Sulphate Wockhardt
HH
MP NP MW PDP
 
1
0
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.comlaw.gov.au